|
|
|
11-50 employees
View all
|
|
Biotechnology
|
|
51 Moulton St, Cambridge, Massachusetts 02138, US
|
|
Modalis Therapeutics Corporation (Tokyo Mothers 4883) is developing precision genetic medicines through epigenetic gene modulation. Modalis is advancing therapies for orphan genetic diseases using its proprietary CRISPR-GNDM technology which enables the locus specific modulation of gene expression or histone modification without the need for double- stranded DNA cleavage, gene editing or base editing. Modalis is headquartered in Tokyo with laboratories and R&D facilities in Cambridge,
|
Modalis Therapeutics Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
75.00%
|
The widely used Modalis Therapeutics email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.
To contact Modalis Therapeutics customer service number in your country click here to find.
Haru Morita is the CEO of Modalis Therapeutics. To contact Haru Morita email at [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.